Publication:
Author Correction: Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial.

Simple item page
dc.contributor.authorDam, Tien
dc.contributor.authorBoxer, Adam L
dc.contributor.authorGolbe, Lawrence I
dc.contributor.authorHöglinger, Günter U
dc.contributor.authorMorris, Huw R
dc.contributor.authorLitvan, Irene
dc.contributor.authorLang, Anthony E
dc.contributor.authorCorvol, Jean-Christophe
dc.contributor.authorAiba, Ikuko
dc.contributor.authorGrundman, Michael
dc.contributor.authorYang, Lili
dc.contributor.authorTidemann-Miller, Beth
dc.contributor.authorKupferman, Joseph
dc.contributor.authorHarper, Kristine
dc.contributor.authorKamisoglu, Kubra
dc.contributor.authorWald, Michael J
dc.contributor.authorGraham, Danielle L
dc.contributor.authorGedney, Liz
dc.contributor.authorO'Gorman, John
dc.contributor.authorHaeberlein, Samantha Budd
dc.contributor.authorPASSPORT Study Group
dc.date.accessioned2023-05-03T13:26:35Z
dc.date.available2023-05-03T13:26:35Z
dc.date.issued2022-10-17
dc.identifier.doi10.1038/s41591-022-02076-8
dc.identifier.essn1546-170X
dc.identifier.pmid36253611
dc.identifier.unpaywallURLhttps://www.nature.com/articles/s41591-022-02076-8.pdf
dc.identifier.urihttp://hdl.handle.net/10668/19574
dc.journal.titleNature medicine
dc.journal.titleabbreviationNat Med
dc.language.isoen
dc.organizationHospital Universitario Virgen del Rocío
dc.pubmedtypePublished Erratum
dc.rights.accessRightsopen access
dc.titleAuthor Correction: Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial.
dc.typeresearch article
dc.type.hasVersionVoR
dspace.entity.typePublication

Files

Collections

SAS - Hospital Universitario Virgen del Rocío

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía